Skin care program for breast cancer survivors on hormone therapy
Part of Cancer, Skin clinical trials.
This study tests whether a skin care program can improve the appearance of your skin and your quality of life while you take an aromatase inhibitor (a hormone therapy) after breast cancer treatment. It is designed for women who are starting this type of therapy for the first time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 18 or older
- You are postmenopausal or your doctor says it's okay to take an aromatase inhibitor
- You have been diagnosed with stage 0 to 3 breast cancer that is hormone receptor-positive (ER/PR positive)
- You have not had chemotherapy or hormone therapy for this breast cancer before
- You are willing to avoid facial treatments like facials, Botox, fillers, or lasers during the study
- You have not taken an aromatase inhibitor in the past for this condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a personalized exercise program during chemotherapy helps breast cancer survivors recover better and feel stronger. You'll use a smartphone app to do guided workouts at home while getting support from exercise coaches.
This trial tests a cognitive behavioral therapy (CBT) based program to help relieve joint and muscle pain caused by aromatase inhibitors, a common hormone therapy for breast cancer. It aims to improve your quality of life and reduce symptoms.
This study measures how your skin changes physically and mechanically during breast cancer treatment. It may help doctors better manage side effects like skin dryness or tightness.
This study offers a program to help people who have completed their main treatment for early-stage breast or prostate cancer. It focuses on follow-up and support during survivorship, and you are still eligible if you are on certain maintenance therapies like hormone therapy.
This study tests whether a special anti-inflammatory diet can help reduce side effects in breast cancer survivors who are taking aromatase inhibitors after menopause. You would be randomly assigned to either follow the diet for 6 months or continue your usual diet, and your health will be monitored.
This trial tests a structured nursing and education program to support people with non-metastatic breast cancer who take hormone-blocking treatment. It may help you manage side effects and stay supported during follow-up, using online questionnaires and scheduled sessions.
Hear when a new Anatomic Stage 0 Breast Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.